That advice has changed in recent decades, as treatments have improved. But pregnancy can still be a precarious enterprise, ...

Weight-based dosing misses accounting for factors such as chronic kidney disease or chronic transaminitis, which could ...

The new weekly 120mg SC formulation, supported by TULIP-SC trial results, offers patients with moderate to severe SLE a self-administered alternative to monthly IV infusions.

AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...

AstraZeneca plc (NASDAQ:AZN) has been granted approval by the U.S. Food and Drug Administration for a new self-injection ...

Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells.

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...

"I always knew something was wrong with me," says Nyobie Gordon-Ricks, a mom of two ...

People living with lupus develop strengths that are unique to this journey, and it’s time we paused to honor and celebrate the strengths of a lupus warrior.

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Rachel McGlynn wanted the choice to have kids to be hers — not dictated by the treatment for her condition. A decade into her ...

Objectives To assess indirect costs (IDC) due to lost productivity in paid/unpaid labour, stratified by sex, in a national ...